COVID 19 is an infectious disease caused by Severe acute respiratory syndrome. Coronavirus 2(SARS-CoV-2) has spread across the world within a very short time and A pandemic situation was declared by WHO on March 11th, 2020. Most important clinical manifestation is interstitial pneumonia. COVID 19 is mainly diagnosed by Reverse transcription polymerase chain reaction (RT-PCR) which has low sensitivity, which demands further investigations.
Although chest CT is standard imaging modality for early diagnosis and management of COVID 19 patients, bedside lung ultrasound has tremendous potential to become an important tool for diagnosis and disease monitoring. Lung ultrasound was described earlier and international protocols are there for its application.
We retrospectively reviewed 100 COVID 19 patients diagnosed with RTPCR, who was monitored with bedside ultrasound at isolation ward in Medical College and Hospital, Kolkata. Interstitial lung involvement was detected with high accuracy in lung ultrasound. The objective of our study is to evaluate ultrasound findings in patients with COVID 19 and highlight typical manifestations and advantages of bedside ultrasound in COVID 19 pneumonia. Our study will help clinical researchers make new guidelines for early diagnosis and disease progression, that will help assessment of disease severity and proper management.
Impact Factor
2022: 6.012
This work is licensed under a